C1FS97 AF NFT

3-methyl-2-oxobutanoate hydroxymethyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihm6pzv3tyeufsg53dwgiv3vsi76wvrc2sbzxpmq7zyd5hql45soa/metadata.json
IPFS of structure file: 
bafybeicksea42iwowrjigrfleb7ozot3wppfgctfivoyrtomicrnlvpaqq/AF-C1FS97-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xA5Ad7b0565B651fcEA9363Bec9dE2576C59B4DA2
First NFT owner address (bech32): 
genesis15kkhkpt9kegle65nvwlvnh39wmzekndzpvscuj
Current NFT ID #286624 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
286624
Accession (UniProt):
C1FS97
Name::
3-methyl-2-oxobutanoate hydroxymethyltransferase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN KYOTO / TYPE A2)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT C1FS97 research and analysis (ICN3D with VR)

FASTA sequences

>sp|C1FS97|PANB_CLOBJ 3-methyl-2-oxobutanoate hydroxymethyltransferase OS=Clostridium botulinum (strain Kyoto / Type A2) OX=536232 GN=panB PE=3 SV=1 MRNTVSTFQELKNKGEKITMLTAYDYSMAKLIDSSGINGILVGDSLGMVCLGYENTLSVTMEDMLHHTKAVVRGTSNALVVGDMPFMSYQTSIYDAVYNAGRFIKEAGAHAVKLEGGATVAEEIKAIVKAQIPVMGHIGLTPQSVNMFGGFKVQGKNEKVAKKLIEDAKILEEAGAFSIVLECIPEKLSKIISESISIPTIGIGAGKYCDGQILVYQDMLSMFSDFKPKFVKSFGNIGESIKDGVSQYIKEVKEAKFPEEKHAFKIDDDVINKLY